Right Ventricular Dysfunction is Common in Patients With Breast Cancer Experiencing Cardiotoxicity During Adjuvant Trastuzumab Therapy

被引：0
|
作者：
Calleja, Anna [1 ]
Poulin, Frederic [1 ]
McDonald, Michael [2 ]
Delgado, Diego H. [1 ]
Thavendiranathan, Paaladinesh [1 ]
机构：
[1] Univ Toronto, Toronto Gen Hosp, Div Cardiol, Peter Munk Cardiac Cntr, Toronto, ON M5G 1L7, Canada
[2] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada
来源：
CIRCULATION | 2013年 / 128卷 / 22期
关键词：
Ventricular function; Echocardiography; Cardiomyopathy;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
18966
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Fcγ-receptor IIa polymorphism and cardiotoxicity in patients with breast cancer treated with adjuvant trastuzumab.
    Cresti, N.
    Jamieson, D.
    Verrill, M. W.
    Pinkilgton, M.
    Boddy, A. V.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [32] Cardiac safety of continuous trastuzumab therapy in breast cancer patients with asymptomatic left ventricular dysfunction.
    Yu, Anthony Francis
    Yadav, Nandini U.
    Eaton, Anne
    Lung, Betty Y.
    Thaler, Howard T.
    Liu, Jennifer
    Hudis, Clifford A.
    Dang, Chau T.
    Steingart, Richard
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [33] Cardiotoxicity in elderly breast cancer patients in treatment with trastuzumab
    Mocerino, C.
    Cacciapuoti, F.
    Caruso, G.
    Taddeo, M.
    Gambardella, A.
    [J]. GIORNALE DI GERONTOLOGIA, 2011, 59 (03) : 140 - 146
  • [34] Cardiotoxicity associated with the use of trastuzumab in breast cancer patients
    Perik, Patrick J.
    de Korte, Maarten Alexander
    van Veldhuisen, Dirk J.
    Gietema, Jourik A.
    Sleijfer, Dirk T.
    de Vries, Elisabeth G. E.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (12) : 1763 - 1771
  • [35] Antioxidant Protection against Trastuzumab Cardiotoxicity in Breast Cancer Therapy
    Mendez-Valdes, Gabriel
    Gomez-Hevia, Francisca
    Bragato, Maria Chiara
    Lillo-Moya, Jose
    Rojas-Sole, Catalina
    Saso, Luciano
    Rodrigo, Ramon
    [J]. ANTIOXIDANTS, 2023, 12 (02)
  • [36] Cardiotoxicity with adjuvant trastuzumab use in breast cancer: A single institution's experience
    Aldiab, Abdurrahman
    [J]. JOURNAL OF THE SAUDI HEART ASSOCIATION, 2010, 22 (03) : 133 - 136
  • [37] Trastuzumab mediated cardiotoxicity in the setting of adjuvant chemotherapy for breast cancer: a retrospective study
    Wadhwa, Deepa
    Fallah-Rad, Nazanin
    Grenier, Debjani
    Krahn, Marianne
    Fang, Tielan
    Ahmadie, Roien
    Walker, Jonathan R.
    Lister, Danica
    Arora, Rakesh C.
    Barac, Ivan
    Morris, Andrew
    Jassal, Davinder S.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2009, 117 (02) : 357 - 364
  • [38] Prevention of cardiotoxicity in adjuvant breast cancer (BC) therapy
    Tomassi, O. M.
    Giovinazzo, P.
    Barro, S.
    Milani, L.
    Bernardi, D.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 18 - 18
  • [39] Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer
    Tarantini, Luigi
    Cioffi, Giovanni
    Gori, Stefania
    Tuccia, Fausto
    Boccardi, Lidia
    Bovelli, Daniella
    Lestuzzi, Chiara
    Maurea, Nicola
    Oliva, Stefano
    Russo, Giulia
    Faggiano, Pompilio
    [J]. JOURNAL OF CARDIAC FAILURE, 2012, 18 (02) : 113 - 119
  • [40] Trastuzumab mediated cardiotoxicity in the setting of adjuvant chemotherapy for breast cancer: a retrospective study
    Deepa Wadhwa
    Nazanin Fallah-Rad
    Debjani Grenier
    Marianne Krahn
    Tielan Fang
    Roien Ahmadie
    Jonathan R. Walker
    Danica Lister
    Rakesh C. Arora
    Ivan Barac
    Andrew Morris
    Davinder S. Jassal
    [J]. Breast Cancer Research and Treatment, 2009, 117 : 357 - 364
12345